TGTX
TG Therapeutics, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders -23.1% ·
aandelenstroom -30.0% ·
netto nieuwe posities -20.0%
— formule
Brede distributie — dalende aandelen en minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 117 | +11 | 84.53M | $4.64B | +13 | −2 |
| Q1 2026 | 109 | 0 | 78.24M | $2.60B | +7 | −7 |
| Q4 2025 | 108 | 0 | 85.68M | $2.55B | — | — |
| Q3 2025 | 18 | +1 | 56.55M | $2.04B | +1 | −1 |
| Q2 2025 | 15 | 0 | 56.34M | $2.03B | +1 | −1 |
| Q1 2025 | 12 | +2 | 14.38M | $567.04M | +2 | — |
| Q4 2024 | 10 | -1 | 14.56M | $438.37M | — | −1 |
| Q3 2024 | 10 | -3 | 5.57M | $130.22M | — | −3 |
| Q2 2024 | 13 | — | 11.93M | $212.32M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passief) | 3.21M | 0.0% | $74.98M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passief) | 3.21M | 0.0% | $74.98M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | Two Sigma Investments ✦ | 1.06M | -21.9% | $24.86M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 4 | Norges Bank ✦ (passief) | 437.46K | -26.8% | $10.23M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | D. E. Shaw & Co. ✦ | 394.78K | +64.5% | $9.23M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | D. E. Shaw & Co. ✦ | 394.78K | +64.5% | $9.23M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 125.13K | -93.3% | $2.93M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | Gotham Asset Management ✦ | 115.28K | +57.3% | $2.70M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 81.50K | -7.3% | $1.91M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | Wellington Management ✦ | 73.32K | +12.7% | $1.71M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Wellington Management ✦ | 73.32K | +12.7% | $1.71M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Wellington Management ✦ | 73.32K | +12.7% | $1.71M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Wellington Management ✦ | 73.32K | +12.7% | $1.71M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 59.44K | +56.3% | $1.39M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 59.44K | +56.3% | $1.39M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 59.44K | +56.3% | $1.39M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | Millennium Management ✦ | 11.79K | -99.2% | $275,862 | 0.0% | ▼ Trim | 2 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Marshall Wace | $36.50M | was 0.1% |
| Point72 Asset Management | $10.42M | was 0.0% |
| Renaissance Technologies | $5.50M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 359 houders, 105.22M aandelen, $3.44B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.